MCGRATH DENNIS M — SEC Form 4 filings
SEC reporting owner CIK 1269340. 13 Form 4 filings on record with FilingPulse; latest filed 2026-04-03.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-03-08 to 2026-04-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | Director | 5 | — | — | 5 |
| Lucid Diagnostics Inc. (LUCD) | Chief Financial Officer | 3 | — | — | 3 |
| DarioHealth Corp. (DRIO) | Director | 2 | — | — | 2 |
| PAVmed Inc. (PAVM) | President and CFO | 2 | — | — | 2 |
| Citius Pharmaceuticals, Inc. (CTXR) | Director | 1 | — | — | 1 |
Form 4 filings — MCGRATH DENNIS M
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-03 | 4 | PAVmed Inc. (PAVM) | Grant/award (A): 180,000 @ $0 | EDGAR |
| 2026-02-24 | 4 | Lucid Diagnostics Inc. (LUCD) | Grant/award (A): 470,000 @ $0 | EDGAR |
| 2025-12-22 | 4/A | CITIUS ONCOLOGY, INC. (CTOR) | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-12-01 | 4/A | CITIUS ONCOLOGY, INC. (CTOR) | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-10-02 | 4 | PAVmed Inc. (PAVM) | Grant/award (A): 150,000 @ $0 | EDGAR |
| 2025-09-23 | 4 | CITIUS ONCOLOGY, INC. (CTOR) | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-09-15 | 4 | DarioHealth Corp. (DRIO) | Grant/award (A): 20,000 @ $0 | EDGAR |
| 2025-02-21 | 4 | Lucid Diagnostics Inc. (LUCD) | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2024-12-16 | 4 | CITIUS ONCOLOGY, INC. (CTOR) | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2024-11-12 | 4 | Citius Pharmaceuticals, Inc. (CTXR) | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2024-08-14 | 4 | CITIUS ONCOLOGY, INC. (CTOR) | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2024-05-08 | 4 | Lucid Diagnostics Inc. (LUCD) | Grant/award (A): 400,000 @ $0 | EDGAR |
| 2024-03-08 | 4 | DarioHealth Corp. (DRIO) | Grant/award (A): 80,000 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1269340 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →